Association between bisphenols A and the risk of endometriosis
Results from an updated meta-analysis
Bibliographic Data
Background Recent studies have disputed the association between bisphenol A (BPA) and endometriosis. This updated meta-analysis was conducted to investigate the impact of BPA exposure on endometriosis. Methods This study evaluated BPA exposure and endometriosis risk, analyzing studies from Web of Science, PubMed, Embase, Cochrane Library, and Chinese databases (CNKI, CBM, Wanfang, VIP) through August 2025. Methodological quality was assessed via the Newcastle-Ottawa Scale (NOS) and the Agency for Healthcare Research and Quality Tool (AHRQ). Heterogeneity was quantified using I 2 statistics. Pooled odds ratios (ORs) and 95% CIs were calculated using fixed- or random-effects models according to heterogeneity. Subgroup analysis, sensitivity analysis, and publication bias assessment were supplemented to validate the overall finding. Results Seven studies comprising 2,488 participants were included in quantitative synthesis. The meta-analyses demonstrated that BPA exposure was associated with a statistically significant increase in endometriosis risk (OR = 1.36, 95% CI = 1.13–1.63, p = 0.008). Additionally, subgroup analysis indicated that BPA exposure may further elevate endometriosis risk in cases with different regions, populations, and measurement methods. Sensitivity analysis confirmed that the results of these meta-analyses were relatively robust. No publication bias was detected. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251019552 , identifier PROSPERO (CRD420251019552)
Endometriosis · MEDLINE · Meta-analysis · Odds ratio · Risk assessment · Subgroup analysis · Effects and risks of endocrine disrupting chemicals · Endometriosis Research and Treatment · Menopause: Health Impacts and Treatments
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Assessing the quality of reports of randomized clinical trials
Prisma-S
A basic introduction to fixed-effect and random-effects models for meta-analysis
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions
Operating Characteristics of a Rank Correlation Test for Publication Bias
Bias in meta-analysis detected by a simple, graphical test
The PRISMA 2020 statement
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Association of Urinary Levels of Bisphenols A, F, and S with Endometriosis Risk
| Highly cited | No |
|---|